Benzinga | Aug 19, 2021 07:33AM EDT

Cantor Fitzgerald Initiates Coverage On Portage Biotech with Overweight Rating, Announces Price Target of $35

Cantor Fitzgerald initiates coverage on Portage Biotech (NASDAQ:PRTG) with a Overweight rating and announces Price Target of $35.